MedPath

Dietary Intervention Replacing Carbohydrate With Protein and Fat Has Greater Effect on Peripheral Blood Mononuclear Cell Metabolites Than on Plasma Metabolites in Patients With Prediabetes or Type-2 Diabetes

Phase 2
Completed
Conditions
Type-2 Diabetes
Prediabetes
Interventions
Dietary Supplement: Dietary intervention-refined rice
Dietary Supplement: Dietary intervention-whole grains and legumes
Registration Number
NCT02191644
Lead Sponsor
Yonsei University
Brief Summary

This study examined whether dietary-induced reductions in lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in peripheral blood mononuclear cells (PBMC) and plasma affected metabolic profiles in PBMCs and plasma.

Detailed Description

Eighty nonobese patients (aged 40-70 years) with prediabetes or newly diagnosed type-2 diabetes were randomly assigned to a control group (normal diet with refined rice) or a whole-grain group (replacement of refined rice with whole-grains and legumes). This dietary intervention replaced approximately 7% of carbohydrate-derived energy with approximately 4% of protein-derived energy and approximately 3% of fat-derived energy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
82
Inclusion Criteria
  • subjects who had IFG (100≤ fasting glucose <126 mg/dL)
  • or newly diagnosed type-2 diabetes (fasting glucose ≥126 mg/dL)
Read More
Exclusion Criteria
  • current and/or past history of cardiovascular disease including angina
  • liver or kidney dysfunction
  • thyroid or pituitary disease
  • pregnancy or lactation
  • taking medications or supplements
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Refined riceDietary intervention-refined rice-
Whole grains and legumesDietary intervention-whole grains and legumes-
Primary Outcome Measures
NameTimeMethod
Lp-PLA2 Activity in PlasmaChange from baseline in Lp-PLA2 at 12 weeks
Lp-PLA2 Activity in PBMCChange from baseline in Lp-PLA2 at 12 weeks
Secondary Outcome Measures
NameTimeMethod
PBMC metabolitesChange in L-leucine, oleamide, lysoPC (16:0), and lysoPC (18:0)

Trial Locations

Locations (1)

Yonsei University

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath